COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study, underpinning a continued push to deliver the shots.
The study by Oxford University researchers, published in the journal Cell, investigated the ability of antibodies in the blood from people, who were vaccinated with the two-shot regimens, to neutralize the highly contagious Delta and Kappa variants, a statement said.
There is no evidence of widespread escape suggesting that the current generation of vaccines will provide protection against the B.1.617 lineage,” the paper said, referring to the Delta and Kappa variants by a commonly used code.
April 5, 2022
February 1, 2022
January 20, 2022
- Telangana Minister KTR Joins South Pushback To Amit Shah Hindi Pitch
- Hatemonger’s Rape Threat To Muslim Women, UP Cops File Case After 6 Days
- Sanath Jayasuriya praises big brother India for helping Sri Lanka amid economic crisis
- US Slams “Deliberate Campaign To Kill, To Torture, To Rape” In Ukraine Bucha
- Biden Outlines Next Phase Of Sanctions On Russia
Ajit Pawar became ‘clean’ as soon as he came with BJP? latestupdatenews.com…
Alcohol, mother, sister and sister-in-law raped latestupdatenews.com…
Now ISRO in preparation for Chandrayaan-3, 12-month deadline latestupdatenews.com…
Pakistan shows a checkered face, said – Kulbhushan Jadhav’s case will not run in civilian court latestupdatenews.com…